SG, P., K, S., J, H., C, B., A, O., T, L., . . . IA, B. (2026). Could we reduce renal toxicity of [177Lu]Lu-PSMA radioligand therapy with furosemide? European journal of nuclear medicine and molecular imaging, 53(9), 5427. https://doi.org/10.1007/s00259-026-07865-8
Chicago Style (17th ed.) CitationSG, Pop, et al. "Could We Reduce Renal Toxicity of [177Lu]Lu-PSMA Radioligand Therapy with Furosemide?" European Journal of Nuclear Medicine and Molecular Imaging 53, no. 9 (2026): 5427. https://doi.org/10.1007/s00259-026-07865-8.
MLA (9th ed.) CitationSG, Pop, et al. "Could We Reduce Renal Toxicity of [177Lu]Lu-PSMA Radioligand Therapy with Furosemide?" European Journal of Nuclear Medicine and Molecular Imaging, vol. 53, no. 9, 2026, p. 5427, https://doi.org/10.1007/s00259-026-07865-8.